Enzon Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1983
Net Income	1.37	-0.19	-0.47	-1.31	-0.98	5.85	5.45	-1.13	21.64	28.8	Upgrade
Share-Based Compensation	0	0	0	0	0	0	0	0	-0.01	-0.03	Upgrade
Other Operating Activities	-0.07	-0.47	-0.03	0.93	7.88	-6.83	1.03	3.73	-6.95	3.57	Upgrade
Operating Cash Flow	1.31	-0.66	-0.5	-0.38	6.91	-0.98	6.47	2.6	14.68	32.34	Upgrade
Operating Cash Flow Growth	-	-	-	-	-	-	148.98%	-82.29%	-54.61%	130.90%	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	0.15	Upgrade
Investing Cash Flow	0	0	0	0	0	0	0	0	0	0.15	Upgrade
Dividends Paid	-1.28	-1.28	-2.02	-0.46	-7.96	0	-6.63	-6.63	-37.56	-4.42	Upgrade
Common Stock Issued	0	0	0	43.6	0	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-0.06	-	-	-	-	-0.01	-0.03	Upgrade
Financing Cash Flow	-1.28	-1.28	-2.02	43.08	-7.96	0	-6.63	-6.63	-37.57	-4.45	Upgrade
Net Cash Flow	0.03	-0.66	-0.5	42.7	-1.05	-0.98	-0.16	-4.03	-22.89	28.04	Upgrade
Free Cash Flow	1.31	-0.66	-0.5	-0.38	6.91	-0.98	6.47	2.6	14.68	32.34	Upgrade
Free Cash Flow Growth	-	-	-	-	-	-	148.98%	-82.29%	-54.61%	131.28%	Upgrade
Free Cash Flow Margin	-	-2534.62%	-71.47%	-730.77%	3335.75%	-14.14%	77.23%	31.03%	84.09%	103.74%	Upgrade
Free Cash Flow Per Share	0.02	-0.01	-0.01	-0.01	0.16	-0.02	0.15	0.06	0.33	0.73	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.